You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GRCE Buy Disclosure
Opaleye Management Inc. · SEC Form 4 · Filed Nov 5, 2026
Buy
Calculated transaction value
$18.48K
Opaleye Management Inc. 10% owner
GRCE
Grace Therapeutics
GRCE
Transaction date
Nov 3, 2026
Public filing date
Nov 5, 2026
Filing lag
Filed 2 days later
GRCE daily price context
Close on/before transaction
$1.84
Nov 3, 2026
First close after public filing
$1.85
Nov 6, 2026
Return after filing · so far
-1.62%
Through Nov 12, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock, par value $0.0001 per share
- Quantity / price
- 10,328 shares @ $1.79
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001493152-26-050313
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$33.02K
Buys / sales
3 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Grace Therapeutics, Inc. GRCE | Buy | Nov 5, 2026 | $5.48K |
| Grace Therapeutics, Inc. GRCE | Buy | Nov 4, 2026 | $9.06K |
| Grace Therapeutics, Inc. GRCE Current | Buy | Nov 3, 2026 | $18.48K |